Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Z-338 Phase III Trial in Paediatric Patients With Functional Dyspepsia
NCT04526119Phase 3Completed
- Sponsor
- Zeria Pharmaceutical Co., Ltd.
- Start
- Feb 2021
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acotiamide in functional dyspepsia (FD), sponsored by Zeria Pharmaceutical Co., Ltd.. Started Feb 2021; status: completed.
02
Drugs
acotiamide
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT04526119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04526119.